Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06640751

The Effect of Interventions for Health Behaviors in Hypertensive Patients

The Effect of Interventions for Health Behaviors in Hypertensive Patients -Based on the PRECEDE-PROCEED Model

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHealth behavior interventionThe program is a group-based intervention provided by a healthcare team consisting of researchers, cardiologists, family doctors, community healthcare workers, psychologists, and health education specialists. The intervention is structured around three modules-predisposing, enabling, and reinforcing factors-that provide a framework for educational interventions aimed at promoting healthy behaviors in hypertensive patients.

Timeline

Start date
2024-10-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2024-10-15
Last updated
2024-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06640751. Inclusion in this directory is not an endorsement.